Halogenated alkyl di-and trisaccharides, pharmaceutical formulations, diagnostic kits and methods of treatment
    3.
    发明申请
    Halogenated alkyl di-and trisaccharides, pharmaceutical formulations, diagnostic kits and methods of treatment 有权
    卤化烷基二 - 和三糖,药物制剂,诊断试剂盒和治疗方法

    公开(公告)号:US20090318381A1

    公开(公告)日:2009-12-24

    申请号:US12310988

    申请日:2007-09-14

    申请人: Bahram Memarzadeh

    发明人: Bahram Memarzadeh

    CPC分类号: C07H3/04 A61K31/715 C07H3/06

    摘要: The present invention relates to a novel family of alkylated halogenated di- and trisaccharides which exhibit pharmaceutical efficacy in the areas of permeation enhancers, anti-microbial effects, anti-fugal effects, facilitation of diagnostic procedures. The invention further includes methods of treatment and diagnostic kits.

    摘要翻译: 本发明涉及一种新颖的烷基化卤代二糖和三糖家族,其在渗透促进剂,抗微生物作用,抗散逸作用,促进诊断程序方面表现出药物功效。 本发明还包括治疗和诊断试剂盒的方法。

    ENZYMATIC SUBSTRATES FOR MULTIPLE DETECTION SYSTEMS
    6.
    发明申请
    ENZYMATIC SUBSTRATES FOR MULTIPLE DETECTION SYSTEMS 有权
    多种检测系统的酶基质

    公开(公告)号:US20090253117A1

    公开(公告)日:2009-10-08

    申请号:US12403790

    申请日:2009-03-13

    摘要: An inventive substrate is provided which includes a substrate compound of formula A-B1-B2-B3-B4: wherein A is a sugar moiety; B1 is a linker moiety allowing the conjugation of moiety A and the remaining structure of the substrate; B2 is a linker moiety with a free reactive amino group so as to be available for reaction with carboxylic acids or detectable tags; B3 contains a permanently charged element such as a quaternary ammonium group so as to increase sensitivity for mass spectrometry analysis; and B4 of various carbon length conferring specificity amongst individual substrates in detection methods. Also provided is a molecule of the formula B1-B2-B3-B4, with similar structural characteristics to an enzymatic product produced by the action of a target enzyme on an inventive substrate. Further provided are methods for using inventive substrates for detecting enzymatic activity.

    摘要翻译: 提供了本发明的底物,其包括式A-B1-B2-B3-B4的底物化合物:其中A是糖部分; B1是连接部分,允许部分A与底物的剩余结构共轭; B2是具有游离反应性氨基的接头部分,以便可用于与羧酸或可检测标签反应; B3含有永久带电元件如季铵基,以提高质谱分析的灵敏度; 和各种碳长度的B4在检测方法中在各个底物之间赋予特异性。 还提供了式B1-B2-B3-B4的分子,其与通过靶酶在本发明底物上的作用产生的酶产物具有相似的结构特征。 还提供了使用本发明的底物检测酶活性的方法。

    Gene differentially expressed in breast and bladder cancer, and encoded polypeptides
    7.
    发明授权
    Gene differentially expressed in breast and bladder cancer, and encoded polypeptides 失效
    在乳腺癌和膀胱癌中差异表达的基因和编码的多肽

    公开(公告)号:US07268207B2

    公开(公告)日:2007-09-11

    申请号:US09824787

    申请日:2001-04-04

    CPC分类号: C07K14/47

    摘要: The present invention relates to a novel human gene that is differentially expressed in human carcinoma. More specifically, the present invention relates to a polynucleotide encoding a novel human polypeptide named C35 that is overexpressed in human breast and bladder carcinoma. This invention also relates to C35 polypeptides, as well as vectors, host cells, antibodies directed to C35 polypeptides, and the recombinant methods for producing the same. The present invention further relates to diagnostic methods for detecting carcinomas, including human breast carcinomas. The present invention further relates to the formulation and use of the C35 gene and polypeptides in immunogenic compositions or vaccines, to induce antibody or cell-mediated immunity against target cells, such as tumor cells, that express the C35 gene. The invention further relates to screening methods for identifying agonists and antagonists of C35 activity.

    摘要翻译: 本发明涉及在人癌中差异表达的新型人基因。 更具体地,本发明涉及编码在人乳腺癌和膀胱癌中过表达的名为C35的新型人多肽的多核苷酸。 本发明还涉及C35多肽,以及载体,宿主细胞,针对C35多肽的抗体及其制备方法。 本发明还涉及用于检测癌症的诊断方法,包括人乳腺癌。 本发明还涉及C35基因和多肽在免疫原性组合物或疫苗中的配制和用途,以诱导针对表达C35基因的靶细胞例如肿瘤细胞的抗体或细胞介导的免疫。 本发明还涉及鉴定C35活性的激动剂和拮抗剂的筛选方法。